Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThruvision Grp Regulatory News (THRU)

Share Price Information for Thruvision Grp (THRU)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 17.50
Bid: 17.00
Ask: 18.00
Change: 0.00 (0.00%)
Spread: 1.00 (5.882%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 17.50
THRU Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year-end trading update

26 Apr 2024 07:00

RNS Number : 1066M
Thruvision Group PLC
26 April 2024
 

26 April 2024

Thruvision Group plc

 

Year-end trading update

 

Thruvision (AIM: THRU, "Thruvision" or the "Group"), the leading international provider of walk-through security technology, today publishes a trading update for the financial year ended 31 March 2024 ("FY24").

 

· Revenue is expected to be in the order of £7.8 million (FY23: £12.4 million), made up primarily by Entrance Security, new Customs agency sales and Retail Distribution.

· Adjusted gross margin* remained strong and improved to 53.0% (FY23: 51.5%).

· The revenue reduction can be attributed to the previously announced lack of further significant orders from US Customs and Border Protection (CBP) in FY24.

· Adjusting for the impact of this single customer, revenue growth was 85% to £7.6 million (FY23: £4.1 million) on a like-for-like basis, demonstrating strong broad-based growth in demand for our solutions.

· US Transportation Security Administration (TSA) has recently changed its policy to require increased security screening of aviation employees, which has led to a meaningful pick-up in sales enquiries which we expect to lead to new sales in FY25.

· Approximately 70% of revenue came from the Group's existing customer base, most of whom were upgrading to our WalkTHRU solution.

· Adjusted EBITDA loss* is expected to be in the region of £2.5 million (FY23: loss of £0.2 million), which is in line with market expectations.

· Cash balance on 31 March 2024 was £4.1 million (31 March 2023: £2.8 million). The Group has no debt.

 

Colin Evans, Chief Executive, commented:

 

"Almost all demand we are now experiencing is for our WalkTHRU technology where our latest AI-based image processing software is further strengthening our market leadership.

 

The very strong revenue growth we achieved from customers outside of US Customs and Border Protection (CBP) is encouraging. In particular, the worsening geopolitical climate resulted in very strong interest from the Entrance Security market, a trend we expect to see continue. The Group's multi-year CBP framework purchasing agreement remains in place for when Congressional funding support returns and recent policy changes are now driving demand from US Aviation.

 

The fact that we are, post COVID, once again operating in four distinct end markets underpins our confidence in our future growth and our expectation that we will reach profitability in the short-term."

 

 

 

 

 

 

 

For further information please contact:

 

Thruvision Group plc +44 (0)1235 425400

Colin Evans, Chief Executive

Victoria Balchin, Chief Financial Officer

 

Investec Investment Banking (NOMAD & Broker) +44 (0)20 7597 5970

Patrick Robb / James Rudd / Sebastian Lawrence

 

Meare Consulting +44 (0) 7990 858548

Adrian Duffield

 

About Thruvision (www.thruvision.com)

 

Thruvision is the leading developer, manufacturer and supplier of advanced AI-based walk-through security technology internationally. Its technology is deployed in more than 20 countries around the world by government and commercial organisations in a wide range of security situations, where large numbers of people need to be screened quickly, safely and efficiently. Thruvision's patented technology is uniquely capable of detecting concealed objects in real time using advanced AI-based detection algorithms.

The Group's offices are near Oxford and Washington DC.

 

* Adjusted EBITDA loss is defined as statutory operating loss before depreciation and amortisation, share based payments and impairment of intangible assets. Adjusted gross margin is defined as the statutory gross margin excluding production overheads.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSELFMIELSEFL
Date   Source Headline
26th Apr 20247:00 amRNSYear-end trading update
18th Mar 20247:00 amRNSWalkTHRU completes operational test and evaluation
1st Feb 20247:00 amRNSNext generation product range & software launched
26th Jan 20247:00 amRNSSales Progress Update
22nd Jan 20242:48 pmRNSHolding(s) in Company
10th Jan 202410:39 amRNSAward of Share Options to Executive Director
28th Nov 202311:50 amRNSBlocklisting update
28th Nov 202311:48 amRNSBlocklisting update
20th Nov 20237:00 amRNSInterim Results
13th Nov 20238:51 amRNSUK retail theft to cost £7.9bn in 2023
6th Nov 20234:27 pmRNSNotice of Interim Results
27th Oct 202311:32 amRNSHolding(s) in Company
26th Oct 20232:34 pmRNSHolding(s) in Company
26th Oct 20232:23 pmRNSHolding(s) in Company
25th Oct 202312:04 pmRNSHolding(s) in Company
24th Oct 20237:00 amRNSResult of placing
23rd Oct 20234:35 pmRNSLaunch of placing
2nd Oct 20237:00 amRNSHalf year trading update
21st Sep 202311:12 amRNSResult of Annual General Meeting
22nd Aug 202311:56 amRNSAward of Share Options to Executive Directors
21st Jul 20237:00 amRNSResults for the year ended 31 March 2023
13th Jul 20235:09 pmRNSNotice of Results
7th Jun 20237:00 amRNSBlocklisting update
7th Jun 20237:00 amRNSBlocklisting update
21st Apr 20237:00 amRNSYear end trading update
3rd Feb 20237:00 amRNSSharesave option grant to Executive Director
12th Jan 202310:24 amRNSChange of Auditor
21st Dec 20227:00 amRNSDirector Share Dealing
19th Dec 20227:00 amRNSInterim Results
15th Dec 20227:00 amRNSCORRECTION - Blocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
13th Dec 20227:00 amRNSBlocklisting Update
30th Nov 20227:00 amRNSNotice of Results
9th Nov 20227:00 amRNSAward of Share Options to Executive Directors
8th Nov 20222:50 pmRNSHolding(s) in Company
26th Oct 202211:50 amRNSResult of AGM
12th Oct 20227:00 amRNSH1 Trading Update
3rd Oct 20227:00 amRNSCBP Framework Agreement and Contract Award
30th Sep 20227:00 amRNSResults for the Year ended 31 March 2022
22nd Sep 20223:00 pmRNSContract Award, Trading Update, Notice of Results
16th Jun 20227:00 amRNSAppointment of Chief Financial Officer
15th Jun 20228:31 amRNSHolding(s) in Company
8th Jun 20223:32 pmRNSBlocklisting update
8th Jun 20223:30 pmRNSBlocklisting update
6th May 202212:12 pmRNSDirector Share Dealing-correction & further trade
20th Apr 20227:00 amRNSDirector Share Dealing
4th Apr 20227:00 amRNSYear End Trading Update and Board Changes
1st Apr 20227:01 amRNSBlocklisting update
1st Apr 20227:00 amRNSBlocklisting update
9th Mar 202212:40 pmRNSDirector Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.